Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
William B. Gerraughty, Jr.
Continuing to serve as Sparta System's (Holmdel, NJ) Chief Financial Officer, William B. Gerraughty, Jr., has also been promoted to Chief Operating Officer where in addition to managing the company's legal and human resource departments he will also oversee the day-to-day operations, provide planning and resource allocation, and advise the CEO and management team on key planning issues and business decisions.
Robert Romance
A new position at Catalent Pharma Solutions (Somerset, NJ), Director of Environmental Health and Safety for Printed Components Business, will be filled by Robert Romance.
Working in the regulatory affairs sector in areas such as wound care, vaccine, and pharmaceutical manufacturing, Elizabeth Vincent will use her past experience in her new position as Regulatory Affairs Manager for Trac Services (Camborne, England).
Elizabeth Vincent
Twenty five years of experience in clinical research and business development has landed Art Ziegler a job as Vice President of Business Development for Prologue Research (Columbus, OH) where he will develop and implement marketing and sales initiatives, and push for the company's services within oncology research and in other business areas.
Art Ziegler
Woodley Equipment (Lancashire, UK) has made two new additions to its team with the appointment of David Wood as Medical Electronics Manager and Joanne Platt as Customer Service Representative.
With a background of 25 years in international financial experience and 10 of those years being spent in the biotechnology industry, Hervé Duchesne de Lamotte was chosen to become ExonHit Therapeutic's (Paris, France) new Chief Financial Officer.
Frontage (Exton, PA) has made several additions to its team, including the appointment of Samir Ghodbane, PhD, to the General Manager of CMC services and CTM manufacturing; Daniel Tang, PhD, as Vice President of DMPK and bioassay for China operations; and Ron Connolly as Senior Vice President of business development.
Filling the role of Vice President of Strategic Alliances for Kforce (Tampa, FL) due to a promotion, Mark Lanfear will become responsible for leading client relationship management and development efforts, as well as forging the partnership strategy for multinational expansion.
After serving as senior vice president of sales and marketing for Brecon Pharmaceutical's (Valley Forge, PA) AmerisourceBergen Packaging Group sister company, Anderson Packaging (Rockford, IL), Peter Belden will now become Brecon's new Managing Director.
Vetter executives, along with Illinois Biotechnology Industry Organization and Economic Development executives, dedicate Vetter's new facility in suburban Chicago.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.